ArticleNPJ breast cancer2019

Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds.

Yvonne Ziegler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.